FDA warning letters highlight recurring patterns, systemic gaps, and evolving priorities that medical device manufacturers ...

This article explains why Latin Americas demographic diversity, cost profile, and accelerating digital health infrastructure ...

Early recognition and mitigation of drug and device integration difficulties are critical to the success of combination ...

This article describes how a mechanism-based risk analysis approach can provide two complementary opportunities for ...

USP 382 introduces system-level, function-specific testing for elastomeric components in parenteral packaging, improving ...

Brazil is rapidly establishing itself as a powerhouse in medical device innovation. This article shares market opportunities, ...